A federal judge in Texas has issued a stay on the FDA's approval of mifepristone, a drug used for medication abortions, which has been met with criticism from abortion rights advocates. The U.S. Department of Justice and President Joe Biden have both released statements in response to the ruling, and the DOJ has filed an appeal and is seeking an immediate stay of the decision. The outcome of the DOJ's appeal could set a precedent for future cases and have a significant impact on access to abortion services in the United States.